| 000 | 01889 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515201210.0 | ||
| 264 | 0 | _c20100203 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1535-5667 | ||
| 024 | 7 |
_a10.2967/jnumed.109.066597 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShen, Sui | |
| 245 | 0 | 0 |
_aImpact of rituximab treatment on (90)Y-ibritumomab dosimetry for patients with non-Hodgkin lymphoma. _h[electronic resource] |
| 260 |
_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cJan 2010 |
||
| 300 |
_a150-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntigens, CD20 _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImage Processing, Computer-Assisted |
| 650 | 0 | 4 |
_aIndium Radioisotopes _xpharmacokinetics |
| 650 | 0 | 4 | _aIsotope Labeling |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdiagnostic imaging |
| 650 | 0 | 4 |
_aOrgan Size _xphysiology |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 | _aRadiometry |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aYttrium Radioisotopes |
| 700 | 1 | _aForero, Andres | |
| 700 | 1 | _aMeredith, Ruby F | |
| 700 | 1 | _aShah, Jatin J | |
| 700 | 1 | _aKnox, Susan J | |
| 700 | 1 | _aWiseman, Gregory A | |
| 700 | 1 | _aUsrey, Marc E | |
| 700 | 1 | _aLobuglio, Albert F | |
| 773 | 0 |
_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 51 _gno. 1 _gp. 150-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2967/jnumed.109.066597 _zAvailable from publisher's website |
| 999 |
_c19390867 _d19390867 |
||